前沿拓展：

ca4414

昆明-成都
機(jī)票631元
9折
**國航CA

[1] 關(guān)秀萍 . 國人眩暈癥的病因及治療綜合分析 [J]. **實用內(nèi)科雜 志, 2005, 25(8): 755-757. DOI:10.3969/j.issn.1005-2194.2005.08.043.

[2] Spiegel R, Kirsch M, Rosin C, et al. Dizziness in the emergency department: an update on diagnosis[J]. Swiss Med Wkly, 2017, 147: w14565. DOI:10.4414/**w.2017.14565.

[3] Saberi A, Pourshafifi e SH, Kazemnejad-Leili E, et al. Ondansetron or promethazine: Which one is better for the treatment of acute peripheral vertigo?[J]. Am J Otolaryngol, 2019, 40(1): 10-15. DOI:10.1016/ j.amjoto.2018.09.010.

[4] Amini A, Heidari K, Asadollahi S, et al. Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: a double blind, randomized clinical trial of effifi cacy and safety[J]. J Vestib Res, 2014, 24(1): 39-47. DOI:10.3233/ VES-130506.

[5] Rowan NM. Diphenidol in vertigo: a controlled clinical evaluation[J]. J Am Geriatr Soc, 1968, 16(5): 618-621. DOI:10.1111/j.1532- 5415.1968.tb02102.x.

[6] Thormann M, Amthauer H, Adolf D, et al. Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI[J]. Eur J Radiol, 2013, 82(5): 768-772. DOI:10.1016/ j.ejrad.2011.08.001.

[7] Hain TC, Uddin M. Pharmacological treatment of vertigo[J]. CNS Drugs, 2003, 17(2): 85-100. DOI:10.2165/00023210-200317020- 00002.

[8] Maldonado Fernández M, Birdi JS, Irving GJ, et al. Pharmacological agents for the prevention of vestibular migraine[J]. Cochrane Database Syst Rev, 2015(6): CD010600. DOI:10.1002/14651858.CD010600. pub2.

[9] Lempert T, von Brevern M. Vestibular migraine[J]. Neurol Clin, 2019,37(4):695-706. DOI: 10.1016/j.ncl.2019.06.003.

[10] Warner JJ, Harrington RA, Sacco RL, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke[J]. Stroke, 2019, 50(12): 3331-3332. DOI:10.1161/ STROKEAHA.119.027708.

[11] **醫(yī)藥教育協(xié)會眩暈專業(yè)委員會 . 血管源性頭暈 / 眩暈診 療**專家共識 [J]. **神經(jīng)免疫學(xué)和**學(xué)雜志 , 2020, 27(4): 253-260. DOI:10.3969/j.issn.1006-2963.2020.04.002.

[12] 中華醫(yī)學(xué)會**學(xué)分會 , 中華醫(yī)學(xué)會**學(xué)分會腦 血管病學(xué)組 . **急性缺血性腦卒中診治指南 2014[J]. 中 華神經(jīng)科雜志 , 2015,48(4):246-257. DOI ：10.3760/cma. j.issn.1006-7876.2015.04.002.

[13] 中華醫(yī)學(xué)會**學(xué)分會 , 中華醫(yī)學(xué)會**學(xué)分會神經(jīng) 血管介入?yún)f(xié)作組 , 急性缺血性腦卒中介入診療指南撰寫 組 . **急性缺血性腦卒中早期血管內(nèi)介入診療指南 [J]. 中華神經(jīng)科雜志 , 2015, 48(5): 356-361. DOI:10.3760/cma. j.issn.1006-7876.2015.05.002.

[14] 中華醫(yī)學(xué)會**學(xué)分會 , 中華醫(yī)學(xué)會**學(xué)分會腦血管 病學(xué)組 . **缺血性腦卒中和短暫性腦缺血發(fā)作二級預(yù)防指 南 2014[J]. 中華神經(jīng)科雜志 , 2015,48(4):258-273. DOI ：10.3760/ cma.j.issn.1006-7876.2015.04.003.

[15] Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies[J]. Lancet Neurol, 2007, 6(5): 456-464. DOI:10.1016/s1474-4422(07)70004-2.

[16] Wu S, Wu B, Liu M, et al. Stroke in China: a**ances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405. DOI:10.1016/s1474-4422(18)30500-3.

[17] 中華醫(yī)學(xué)會**學(xué)分會 , 中華醫(yī)學(xué)會**學(xué)分會腦血管病 學(xué)組 . **腦出血診治指南 (2014)[J]. 中華神經(jīng)科雜志 , 2015, 48(6): 435-444. DOI:10.3760/cma.j.issn.1006-7876.2015.06.002.

[18] Nabors LB, Portnow J, Ahluwalia M, et al. Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020,18(11):1537-1570. DOI: 10.6004/jnccn.2020.0052.

[19] Carroll WM, Saida T, Kim HJ, et al. A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)[J]. Mult Scler, 2013, 19(10): 1371-1380. DOI:10.1177/1352458512471092.

[20] Prayoonwiwat N, Siritho S. White matter disease: Early treatment of inflfl ammatory demyelinating disease[J]. Nat Rev Neurol, 2013, 9(5): 246-247. DOI:10.1038/nrneurol.2013.59.

[21] Dorsett M, Liang SY. Diagnosis and treatment of central nervous system infections in the emergency department[J]. Emerg Med Clin North Am, 2016, 34(4): 917-942. DOI:10.1016/j.emc.2016.06.013.

[22] Meyfroidt G, Kurtz P, Sonneville R. Critical care management of infectious meningitis and encephalitis[J]. Intensive Care Med, 2020, 46(2): 192-201. DOI:10.1007/s00134-019-05901-w.

[23] Feil K, Strobl R, Schindler A, et al. What is behind cerebellar vertigo and dizziness?[J]. Cerebellum, 2019, 18(3): 320-332. DOI:10.1007/ s12311-018-0992-8.

[24] Bouccara D, Rubin F, Bonfifi ls P, et al. Management of vertigo and dizziness[J]. Rev Med Interne, 2018, 39(11): 869-874. DOI:10.1016/ j.revmed.2018.02.004.

[25] Y?lmaz A, Abseyi SN. Clinical and demographic characteristics ·406· 中華急診醫(yī)學(xué)雜志 2021 年 4 月第 30 卷第 4 期 Chin J Emerg Med, April 2021, Vol. 30, No. 4 of children and adolescents with acute vertigo symptoms: a crosssectional study[J]. Turk J Med Sci, 2020, 50(8): 1951-1954. DOI:10.3906/sag-2010-228.

[26] Alyono JC. Vertigo and dizziness: understanding and managing fall risk[J]. Otolaryngol Clin North Am, 2018, 51(4): 725-740. DOI:10.1016/j.otc.2018.03.003.

[27] Girasoli L, Cazzador D, Padoan R, et al. Update on vertigo in autoimmune disorders, from diagnosis to treatment[J]. J Immunol Res, 2018, 2018: 5072582. DOI:10.1155/2018/5072582.

[28] Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxy**al positional vertigo (update) executive summary[J]. Otolaryngol Head Neck Surg, 2017, 156(3): 403-416. DOI:10.1177/0194599816689660.

[29] Sajjadi H, Paparella MM. Ménière's disease[J]. Lancet, 2008,372(9636):406-414. doi: 10.1016/S0140-6736(08)61161-7. [30] Tassinari M, Mandrioli D, Gaggioli N, et al. Ménière's disease treatment: a patient-centered systematic review[J]. Audiol Neurootol, 2015, 20(3): 153-165. DOI:10.1159/000375393.

[31] Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: ménière's disease.[J] otolar Head Neck Surg, 2020,162(2_ suppl):S1-S55. doi: 10.1177/0194599820909437. [32] Tokle G, M?rkved S, Br?then G, et al. Efficacy of vestibular rehabilitation following acute vestibular neuritis: a randomized controlled trial[J]. Otol Nearotol, 2020, 41(1): 78-85. DOI:10.1097/ MAO.0000000000002443.

[33] Goudakos JK, Markou KD, Psillas G, et al. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(5): 434-440. DOI:10.1001/jamaoto.2014.48.

[34] Baloh RW. Vestibular Neuritis[J]. N Engl j med, 2003,348(11):1027- 1032.

[35] MacFadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations[J]. Cochrane Database Syst Rev, 2006(1): CD005608. DOI:10.1002/14651858.CD005608.

[36] Harris AS, Elhassan HA, Flook EP. Why are ototopical aminoglycosides still fifi rst-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones[J]. J Laryngol Otol, 2016, 130(1): 2-7. DOI:10.1017/S0022215115002509.

[37] Mittal R, Lisi CV, Gerring R, et al. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media[J]. J Med Microbiol, 2015, 64(10): 1103-1116. DOI:10.1099/ jmm.0.000155.

[38] Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update)[J]. Otolaryngol Head Neck Surg, 2019, 161(1_suppl): S1-S45. DOI:10.1177/0194599819859885.

[39] Staab JP. Psychiatric considerations in the management of dizzy patients[J]. A** Otorhinolaryngol, 2019, 82: 170-179. DOI:10.1159/000490286.

[40] Battle DE. Diagnostic and statistical manual of mental disorders (D**)[J]. CoDAS, 2013, 25(2): 191-192. DOI:10.1590/s2317- 17822013000200017.

[41] Sklare DA, Stein MB, Pikus AM, et al. Dysequilibrium and audiovestibular function in panic disorder: symptom profifi les and test fifi ndings[J]. Am J Otol, 1990, 11(5): 338-341.

[42] Iengo A. Brief strategic therapy in panic disorder treatment[J]. Psychiatr Danub, 2020, 32(Suppl 1): 75-78.

[43] **醫(yī)藥教育協(xié)會眩暈專業(yè)委員會，**康復(fù)醫(yī)學(xué)會眩暈與康 復(fù)專業(yè)委員會，中西醫(yī)結(jié)合學(xué)會眩暈專業(yè)委員會，**研究 型醫(yī)院學(xué)會聽覺醫(yī)學(xué)專業(yè)委員會 . 前庭前庭功能檢查專家共識 （一）中華耳科學(xué)雜志，2019，17（1）117-123, DOI:10.3969/ j.issn,1672-2922.2019.01.020.

[44] **醫(yī)藥教育協(xié)會眩暈專業(yè)委員會，**康復(fù)醫(yī)學(xué)會眩暈與 康復(fù)專業(yè)委員會，中西醫(yī)結(jié)合學(xué)會眩暈專業(yè)委員會，**研 究型醫(yī)院學(xué)會聽覺醫(yī)學(xué)專業(yè)委員會 . 前庭功能檢查專家共識 ( 二 )[J]. 中華耳科學(xué)雜志 , 2019, 17(2): 144-149. DOI:10.3969/ j.issn,1672-2922.2019.02.002.

拓展知識：

ca4414

進(jìn)入空間后,點[自定義],第二把鼠標(biāo)放在每個模塊的右上角,會發(fā)現(xiàn)出現(xiàn)編輯和隱藏字樣,全部隱藏就可以

ca4414

點我的裝扮 進(jìn)入后把你的裝扮全部取消
或者在頁面**點一個掛件他會有隱藏
你點了之后在保存就可以了

ca4414

進(jìn)入空間后,點[自定義],第二點最后一個恢復(fù)默認(rèn),確定保存就好了

ca4414

你用這個圖片 http://sz.photo.store.qq.com/http_imgload.cgi?/rurl2=6d78ed4d7095466bbd87bf823ca4da01408db165138598f5834f89f13544dae0a13e414f1ccb3aa667d847e8123302883a940114de3f701a57ae21066b5014679ca7bf663d40fb8c44e476b368cf8337fae4414e

新建一個圖片模塊. 把設(shè)置邊框里面的 更多設(shè)置里面的

模塊背景,邊框 : 的"無"給選上. 最后新建模塊.

保存后就可以了. 例子見:http://user.qzone.qq.com/384176574

本回答被提問者采納